Source:http://linkedlifedata.com/resource/pubmed/id/18479222
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
2008-5-15
|
| pubmed:abstractText |
Recent evidence has established the non receptor tyrosine kinase, Src, as a critical component of multiple signalling pathways that regulate proliferation, survival, angiogenesis and metastasis. Increased levels of Src protein and activity are widely reported in human cancers including breast cancer, and its important role in oncogenic processes makes it a potential target for therapeutic intervention.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
1744-7631
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
12
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
757-67
|
| pubmed:dateRevised |
2009-11-19
|
| pubmed:meshHeading |
pubmed-meshheading:18479222-Animals,
pubmed-meshheading:18479222-Antineoplastic Agents,
pubmed-meshheading:18479222-Breast Neoplasms,
pubmed-meshheading:18479222-Clinical Trials as Topic,
pubmed-meshheading:18479222-Drug Evaluation, Preclinical,
pubmed-meshheading:18479222-Humans,
pubmed-meshheading:18479222-Protein Kinase Inhibitors,
pubmed-meshheading:18479222-src-Family Kinases
|
| pubmed:year |
2008
|
| pubmed:articleTitle |
Src inhibitors in breast cancer therapy.
|
| pubmed:affiliation |
RCUK Academic Fellow Cardiff University, Welsh School of Pharmacy, Redwood Building, King Edward VII Avenue, Cardiff, CF10 3XF, UK. HiscoxSE1@cf.ac.uk
|
| pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|